Nkarta (NKTX) Cash from Financing Activities (2019 - 2026)

Nkarta's (NKTX) quarterly Cash from Financing Activities came in at $6000.0 in Q1 2026, down 90.62% quarter-over-quarter from $64000.0 in Q4 2025.

Nkarta (NKTX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Nkarta's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $6000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $6000.0 in Q1 2026; TTM through Mar 2026 was $147000.0, a 180.77% increase from a year earlier, with the FY2025 full-year figure at $141000.0, down 99.94% from the prior year.
  • Cash from Financing Activities retreated to $6000.0 in Q1 2026 per NKTX's latest filing, from $64000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $226.3 million in Q1 2024 and bottomed at -$368000.0 in Q2 2024.
  • The 5-year median for Cash from Financing Activities is $131500.0 (2022), against an average of $31.9 million.
  • Biggest YoY gain for Cash from Financing Activities was 22626500.0% in 2024; the steepest drop was 193.16% in 2024.
  • Year by year, Cash from Financing Activities stood at $424000.0 in 2022, then slumped by 30.42% to $295000.0 in 2023, then sank by 37.63% to $184000.0 in 2024, then plunged by 65.22% to $64000.0 in 2025, then sank by 90.62% to $6000.0 in 2026.
  • Per Business Quant, the three latest NKTX Cash from Financing Activities figures stand at $6000.0 (Q1 2026), $64000.0 (Q4 2025), and $77000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Nkarta 170.79 Mn 170.79 Mn - 6,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00
Jun 30, 2025 77,000.00
Jun 30, 2025 77,000.00
Dec 31, 2024 184,000.00
Dec 31, 2024 184,000.00
Sep 30, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 -368,000.00
Jun 30, 2024 -368,000.00
Mar 31, 2024 226.27 Mn
Mar 31, 2024 226.27 Mn
Dec 31, 2023 295,000.00
Dec 31, 2023 295,000.00
Jun 30, 2023 395,000.00
Jun 30, 2023 395,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00